IP Library Granted Patent US 9,074,225
Granted Patent B2
US 9,074,225 · App. 12/821,107 · Granted Jul 7, 2015

Biosynthesis of 1-alkenes in engineered microorganisms

Inventors: Christian Perry Ridley (Acton, MA); Nikos Basil Reppas (Brookline, MA)
Assignee: Joule Unlimited Technologies, Inc.
C12P5/026C12N1/12C12N9/1029
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,074,225
App. No.
12/821,107
Granted
Jul 7, 2015
Kind
B2
Abstract

Various 1-alkenes, including 1-nonadecene and 1-octadecene, are synthesized by the engineered microorganisms and methods of the invention. In certain embodiments, the microorganisms comprise recombinant 1-alkene synthases. The engineered microorganisms may be photosynthetic microorganisms such as cyanobacteria.

Claims (23)

1. A method for the biosynthetic production of 1-alkenes, comprising:

culturing an engineered microorganism in a culture medium, wherein said engineered microorganism comprises a recombinant 1-alkene synthase, wherein said 1-alkene synthase is at least 95% identical to SEQ ID NO: 2, and wherein the amount of said 1-alkenes produced by said engineered microorganism is greater than the amount that would be produced by an otherwise identical microorganism, cultured under identical conditions, but lacking said recombinant 1-alkene synthase.

2. The method of claim 1 , wherein said recombinant 1-alkene synthase is an endogenous 1-alkene synthase expressed, at least in part, from a promoter other than its native promoter.

3. The method of claim 1 , wherein said recombinant 1-alkene synthase is a heterologous 1-alkene synthase.

4. The method of claim 1 , wherein said recombinant 1-alkene synthase is expressed from a heterologous promoter.

5. The method of claim 4 , wherein said 1-alkene synthase is endogenous to said microorganism.

6. The method of claim 1 , wherein said engineered microorganism is a photosynthetic microorganism, and wherein exposing said engineered microorganism to light and carbon dioxide results in the production of alkenes by said microorganism.

7. The method of claim 6 , wherein said engineered microorganism is a cyanobacterium.

8. The method of claim 1 or 6 , wherein said 1-alkenes are selected from the group consisting of 1-nonadecene and 1-octadecene.

9. The method of claim 1 or 6 , further comprising isolating said 1-alkenes from said cyanobacterium or said culture medium.

10. A method for the biosynthetic production of an olefin, comprising

(1) culturing a cyanobacterium in a culture medium, wherein said cyanobacterium comprises a 1-alkene synthase activity, wherein said 1-alkene synthase is at least 95% identical to SEQ ID NO: 2, and wherein said culture medium comprises an exogenous fatty acid;

(2) exposing said engineered cyanobacterium to light and carbon dioxide, wherein said exposure results in the production of an olefin by said cyanobacterium, and wherein the amount of said olefin produced is greater than the amount that would be produced by an otherwise identical cyanobacterium, cultured under identical conditions but in the absence of said exogenous fatty acid.

11. The method of claim 10 , wherein said concentration of said fatty acid in said culture medium is at least 1 μg/ml.

12. The method of claim 11 , wherein said fatty acid is an odd-chain fatty acid.

13. The method of claim 12 , wherein said odd-chain fatty acid is tridecanoic acid and said olefin is 1-octadecene.

14. The method of claim 13 , wherein the amount of said 1-octadecene produced is at least 0.039% dry cell weight.

15. The method of claim 10 , further comprising isolating said olefin from said cyanobacterium or said culture medium.

16. A method for the biosynthetic production of alkenes, comprising

(1) culturing an engineered microorganism in a culture medium, wherein said engineered microorganism comprises a modification, wherein said modification reduces the activity of a hydrolase having an amino acid sequence that has at least 95% sequence identity to SEQ ID NO:4; and

(2) exposing said engineered microorganism to light and carbon dioxide, wherein said exposure results in the production of alkenes by said engineered microorganisms, wherein said alkenes comprise 1-alkenes, and wherein the amount of 1-alkenes produced is greater than the amount that would be produced by an otherwise identical microorganism, cultured under identical conditions, but lacking said modification.

17. The method of claim 16 , wherein said 1-alkenes include 1-nonadecene.

18. The method of claim 16 , wherein said microorganism is a cyanobacteria.

Assignments (3)
SECURITY INTEREST Recorded Jun 23, 2016
From: JOULE UNLIMITED TECHNOLOGIES, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 039140/0200 →
CHANGE OF NAME Recorded Sep 20, 2011
From: JOULE UNLIMITED, INC.
To: JOULE UNLIMITED TECHNOLOGIES, INC.
Reel/Frame 026938/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2011
From: RIDLEY, CHRISTIAN PERRY; REPPAS, NIKOS BASIL
To: JOULE UNLIMITED, INC.
Reel/Frame 025756/0322 →
Continuity (2)
Provisional Application 61219369 · Jun 22, 2009
Related Publication 20100330642A1 · Dec 30, 2010